Predictive value of lymph node metastases and extracapsular extension for the risk of distant metastases in laryngeal carcinoma. 2006

Stephanie Oosterkamp, and Jos M A de Jong, and Piet L Van den Ende, and Johannes J Manni, and Cary Dehing-Oberije, and Bernd Kremer
Department of Otorhinolaryngology and Head & Neck Surgery, Maastricht, The Netherlands.

OBJECTIVE The objective of this retrospective chart analysis was to determine the prognostic value of the lymph node status and extracapsular lymph node extension (ECE) of the neck for the development of distant metastases in squamous cell carcinoma of the larynx. METHODS One hundred sixty-five patients treated for laryngeal carcinoma with a neck dissection with histologic evaluation were included. Primary study end point was distant metastasis-free survival. Univariate analysis with the Kaplan-Meier method was used to calculate distant metastasis-free survival and overall survival for the whole group and for groups according to ECE/lymph node status. Patients were classified as 1) no metastatic lymph nodes, 2) metastatic lymph nodes without ECE, or 3) metastatic lymph nodes with ECE. Univariate Cox regression was performed with outcome distant metastasis-free survival. RESULTS The median overall survival for the whole group was 5.1 years and the 5-year survival rate was 51%. The median distant metastasis-free survival for the whole group could not be calculated and the 5-year metastasis-free survival rate was 78%. The hazard ratio was 3.4 (95% confidence interval [CI] = 1.0-12.1) for patients with positive nodes and without ECE and 10.5 (95% CI = 3.6-30.8) for the patients with metastatic nodes and with ECE compared with the patients without metastatic lymph nodes. CONCLUSIONS The presence of ECE in metastatic lymph nodes augments the risk of distant metastasis by nine times in laryngeal carcinoma. Metastatic lymph nodes without ECE show a risk three times greater.

UI MeSH Term Description Entries
D007822 Laryngeal Neoplasms Cancers or tumors of the LARYNX or any of its parts: the GLOTTIS; EPIGLOTTIS; LARYNGEAL CARTILAGES; LARYNGEAL MUSCLES; and VOCAL CORDS. Cancer of Larynx,Laryngeal Cancer,Larynx Neoplasms,Cancer of the Larynx,Larynx Cancer,Neoplasms, Laryngeal,Cancer, Laryngeal,Cancer, Larynx,Cancers, Laryngeal,Cancers, Larynx,Laryngeal Cancers,Laryngeal Neoplasm,Larynx Cancers,Larynx Neoplasm,Neoplasm, Laryngeal,Neoplasm, Larynx,Neoplasms, Larynx
D008198 Lymph Nodes They are oval or bean shaped bodies (1 - 30 mm in diameter) located along the lymphatic system. Lymph Node,Node, Lymph,Nodes, Lymph
D008207 Lymphatic Metastasis Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system. Lymph Node Metastasis,Lymph Node Metastases,Lymphatic Metastases,Metastasis, Lymph Node
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Stephanie Oosterkamp, and Jos M A de Jong, and Piet L Van den Ende, and Johannes J Manni, and Cary Dehing-Oberije, and Bernd Kremer
January 2008, Gynecologic oncology,
Stephanie Oosterkamp, and Jos M A de Jong, and Piet L Van den Ende, and Johannes J Manni, and Cary Dehing-Oberije, and Bernd Kremer
January 2005, The American journal of surgical pathology,
Stephanie Oosterkamp, and Jos M A de Jong, and Piet L Van den Ende, and Johannes J Manni, and Cary Dehing-Oberije, and Bernd Kremer
October 2005, The Journal of urology,
Stephanie Oosterkamp, and Jos M A de Jong, and Piet L Van den Ende, and Johannes J Manni, and Cary Dehing-Oberije, and Bernd Kremer
March 2005, Annals of surgical oncology,
Stephanie Oosterkamp, and Jos M A de Jong, and Piet L Van den Ende, and Johannes J Manni, and Cary Dehing-Oberije, and Bernd Kremer
August 1997, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc,
Stephanie Oosterkamp, and Jos M A de Jong, and Piet L Van den Ende, and Johannes J Manni, and Cary Dehing-Oberije, and Bernd Kremer
January 2004, Tumori,
Stephanie Oosterkamp, and Jos M A de Jong, and Piet L Van den Ende, and Johannes J Manni, and Cary Dehing-Oberije, and Bernd Kremer
August 1985, Archives of otolaryngology (Chicago, Ill. : 1960),
Stephanie Oosterkamp, and Jos M A de Jong, and Piet L Van den Ende, and Johannes J Manni, and Cary Dehing-Oberije, and Bernd Kremer
June 2011, BMC cancer,
Stephanie Oosterkamp, and Jos M A de Jong, and Piet L Van den Ende, and Johannes J Manni, and Cary Dehing-Oberije, and Bernd Kremer
October 2009, Zhonghua zhong liu za zhi [Chinese journal of oncology],
Stephanie Oosterkamp, and Jos M A de Jong, and Piet L Van den Ende, and Johannes J Manni, and Cary Dehing-Oberije, and Bernd Kremer
August 2019, Journal of medical imaging and radiation oncology,
Copied contents to your clipboard!